To include your compound in the COVID-19 Resource Center, submit it here.

Highlights of weekly biotech stock moves

Regulatory, clinical and other milestones

Regulatory milestones

Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) gained $0.88 (22%) to $4.86 on Monday after clarifying the regulatory path in the U.S. for Northera droxidopa to treat neurogenic orthostatic hypotension (NOH). Chelsea still plans to submit an NDA next quarter based on efficacy data from two completed Phase III studies, Study 301 and Study 302. Chelsea finished the week up $1.02 (26%) to $5 (see B14).

NicOx S.A. (Euronext:COX) fell €0.46 (20%) to €1.82 on Wednesday after withdrawing an MAA in Europe for naproxcinod for osteoarthritis (OA). The company

Read the full 876 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers